New York State Teachers Retirement System Sells 1,000 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

New York State Teachers Retirement System lessened its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 3.6% during the 3rd quarter, HoldingsChannel reports. The firm owned 26,566 shares of the medical instruments supplier’s stock after selling 1,000 shares during the period. New York State Teachers Retirement System’s holdings in ICU Medical were worth $4,841,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Motco bought a new position in ICU Medical in the first quarter valued at approximately $29,000. Innealta Capital LLC bought a new stake in ICU Medical in the 2nd quarter valued at $32,000. Hexagon Capital Partners LLC boosted its stake in ICU Medical by 162.7% in the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 122 shares during the period. Allworth Financial LP increased its holdings in ICU Medical by 100.0% during the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Finally, EntryPoint Capital LLC raised its stake in shares of ICU Medical by 731.5% in the 1st quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 395 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on ICUI shares. Jefferies Financial Group began coverage on ICU Medical in a report on Monday, October 14th. They set a “hold” rating and a $183.00 price objective for the company. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 12th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Thursday, October 10th. Raymond James lifted their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. Finally, KeyCorp increased their price objective on shares of ICU Medical from $147.00 to $198.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $170.25.

ICU Medical Price Performance

Shares of ICUI opened at $173.39 on Wednesday. The company has a market cap of $4.23 billion, a price-to-earnings ratio of -59.38 and a beta of 0.66. The company has a current ratio of 2.41, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76. The company’s fifty day simple moving average is $174.27 and its 200 day simple moving average is $138.31. ICU Medical, Inc. has a 1-year low of $78.28 and a 1-year high of $188.53.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.56. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The company had revenue of $596.50 million for the quarter, compared to analysts’ expectations of $556.64 million. During the same period in the prior year, the firm earned $1.58 EPS. ICU Medical’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, research analysts forecast that ICU Medical, Inc. will post 3.81 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total value of $295,425.50. Following the completion of the sale, the vice president now directly owns 4,482 shares of the company’s stock, valued at $645,901.02. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, VP Daniel Woolson sold 2,502 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $163.22, for a total value of $408,376.44. Following the transaction, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total transaction of $295,425.50. Following the sale, the vice president now owns 4,482 shares of the company’s stock, valued at $645,901.02. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 52,552 shares of company stock valued at $8,741,402 over the last 90 days. 6.70% of the stock is currently owned by insiders.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.